Related Experiment Video

Updated: Sep 28, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Aspirin in coronary heart disease. Comparison of six clinical trials

P L Canner

    Israel Journal of Medical Sciences
    |May 1, 1983
    PubMed

    Insights

    Daily aspirin use in post-myocardial infarction (MI) patients showed a 10% reduction in total mortality, particularly in the first year. However, aspirin also increased risks of gastrointestinal side effects and elevated blood pressure.

    Area of Science:

    • Cardiology
    • Clinical Pharmacology

    Background:

    • Post-myocardial infarction (MI) management aims to reduce mortality and reinfarction.
    • Aspirin is a widely used antiplatelet agent with known benefits and risks.

    Purpose of the Study:

    • To meta-analyze randomized, placebo-controlled trials of aspirin in post-MI patients.
    • To quantify the overall effect of aspirin on mortality and morbidity after MI.

    Main Methods:

    • Combined data from six randomized, placebo-controlled clinical trials.
    • Included 10,703 patients who had experienced a myocardial infarction.
    • Adjusted for prognostically important baseline factors.

    Main Results:

    • Aspirin demonstrated a 10% reduction in total mortality (P = 0.044).
    • Beneficial effects were most pronounced in the first year post-MI.
    • Significant reductions in nonfatal MI and MI-related hospitalizations were observed.
    • Adverse effects included gastrointestinal issues (stomach pain, heartburn, vomiting), elevated systolic blood pressure (>160 mm Hg), and increased serum urea nitrogen and uric acid levels.

    Conclusions:

    • Daily aspirin therapy offers a significant survival benefit for post-MI patients.
    • The benefits of aspirin in reducing mortality and reinfarction must be weighed against its potential adverse effects.
    • Further research may explore optimal duration and patient selection for aspirin therapy.

    More Related Videos

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

    Published on: February 3, 2021

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

    Published on: March 15, 2022

    Related Concept Videos

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...